BMC Medical Co., Ltd.

SZSE:301367 Stock Report

Market Cap: CN¥5.6b

BMC Medical Past Earnings Performance

Past criteria checks 3/6

BMC Medical has been growing earnings at an average annual rate of 34.9%, while the Medical Equipment industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 32.8% per year. BMC Medical's return on equity is 13.8%, and it has net margins of 28.3%.

Key information

34.9%

Earnings growth rate

-7.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate32.8%
Return on equity13.8%
Net Margin28.3%
Next Earnings Update12 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How BMC Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:301367 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 231,346381162123
30 Jun 231,599471153104
31 Mar 231,68948314781
31 Dec 221,41538013573
30 Sep 221,22329711661
01 Jan 226631469648
31 Dec 205602288334
31 Dec 19258396726
31 Dec 18189254725

Quality Earnings: 301367 has a high level of non-cash earnings.

Growing Profit Margin: 301367's current net profit margins (28.3%) are higher than last year (24.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301367's earnings have grown significantly by 34.9% per year over the past 5 years.

Accelerating Growth: 301367's earnings growth over the past year (28.5%) is below its 5-year average (34.9% per year).

Earnings vs Industry: 301367 earnings growth over the past year (28.5%) exceeded the Medical Equipment industry 6.9%.


Return on Equity

High ROE: 301367's Return on Equity (13.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.